All Type of News
New healthcare plan draws strong protest
The government’s plan to increase fees for medication prescribed by general hospitals is also drawing from hospitals.
Officials from general hospitals said that more patients with severe illness have made their fre...
Think tank calls for supermarket sales of over-the-counter drugs
The National Assembly Research Service has recently issued a statement supporting the sales of non-prescription drugs at convenient stores.
There are relatively safe medicines which have little possibility of serio...
Health insurance deficit may be flexible
The National Health Insurance Corp. expects a 16 trillion won deficit in 2020 if it fails to come up with effective measures to counter snowballing shortfalls, its policy research institute said Monday.
The Health ...
Hospital’s medical service to get ratings
The Cabinet meeting Tuesday approved a plan to set up a medical rating agency, aiming to upgrade the service quality of hospitals here and help patients make better choices.
The agency, which is composed of 15 repr...
Chong Kun Dang’s antihypertensive Dilatrend sales top 66 billion won
Pfizer’s Norvask (amlodipine mesilate) has boasted the highest annual revenue in Korea’s competitive hypertensive market for the past years. But last year, the company’s flagship product is being challenged by Chong ...
Pharmaceutical firms oppose DTC prescription drug ads
Korean drug companies are skeptical over the government’s plan to allow the direct to consumer prescription drug advertising, citing the clash between doctors and pharmacists over who gets the right to prescribe medic...
Government urged to define scope of prescription drugs and OTCs
Pharmacists have asked the government to work out measures to reclassify all drugs into prescription drugs and over-the-counter drugs, so many pharmacies nationwide can open all year round and duty-pharmacies to marke...
BioAsia 2011 helps Korean companies enhance mutual cooperation with Indian companies
The Global BioBusiness Forum, BioAsia 2011, is expected to help Korean companies accelerate their inroads into Asia's fourth-largest economy and solidify their presence there, the Korea Drug Research Association said ...
Drug firm fined for illegal rebate
The government is taking a carrot-and-stick approach to the pharmaceutical industry, by encouraging development of new drugs with possible tax incentives on one hand and forcing two pharmaceutical firms to suspend ope...
Pharmaceutical firms urged to enhance risk management
Pharmaceutical companies should every effort to beef up their risk management as some pharmacies neighboring at general hospitals have requested wholesalers to extend their due drug payment until four month, said a ma...
